Prevalence and Impact of Vitamin D Deficiency in Critically Ill Cancer Patients Admitted to the Intensive Care Unit
Nutrients. 2020 Dec 23;13(1):E22. doi: 10.3390/nu13010022.
Nina Buchtele 1, Elisabeth Lobmeyr 1, Julia Cserna 1, Christian Zauner 2, Gottfried Heinz 3, Gürkan Sengölge 4, Wolfgang R Sperr 1 5, Thomas Staudinger 1, Peter Schellongowski 1, Philipp Wohlfarth 1 6
- Deaths from many types of Cancer associated with low vitamin D- review of meta-analyses Sept 2020
- Vitamin D and Cancer Mortality – review Jan 2013
- Vitamin D Supplements Reduce Cancer Mortality – Greger Sept 2019
- Vitamin D reduced Breast Cancer mortality in 9 out of 9 studies, yet still no consensus – April 2019
- Cancer incidence and mortality is decreased if 40-60 ng of Vitamin D – April 2019
- ICU patients 30 percent less likely to die if have enough vitamin D – meta-analysis Nov 2016
- Mortality and vitamin D – great chart
- Risk of Cancer increased if poor Vitamin D Receptor – meta-analysis of 73 studies Jan 2016
- Cancer (general) and VDR
- Breast Cancer and VDR
- Colon Cancer and VDR
- Prostate Cancer and VDR
- Skin Cancer and VDR
- Note some Health problems, such as some Cancers, protect themselves by actively reducing Receptor activation
Vitamin D deficiency is frequent in cancer patients and a risk factor for morbidity and mortality during critical illness. This single-center retrospective study analyzed 25-hydroxyvitamin D levels in critically ill cancer patients (n = 178; hematologic, n = 108; solid, n = 70) enrolled in a prospective ICU registry. The primary analysis was the prevalence of vitamin D deficiency (<20 ng/mL) and the severe deficiency (≤12 ng/mL).
Secondary analyses included risk factors for vitamin D deficiency and its impact on ICU, hospital, and 1-year mortality. The prevalence of vitamin D deficiency and severe deficiency was 74% (95% CI: 67-80%) and 54% (95% CI: 47-61%). Younger age, relapsed/refractory disease, and a higher sepsis-related organ failure assessment (SOFA) score were independent risk factors for vitamin D deficiency (p < 0.05). After adjusting for relapsed/refractory disease, infection, the SOFA score, and the early need for life-supporting interventions, severe vitamin D deficiency was an independent predictor of hospital mortality (OR: 2.21, 95% CI: 1.03-4.72, p = 0.04) and 1-year mortality (OR: 3.40, 95% CI: 1.50-7.71, p < 0.01), but not of ICU mortality.
Conclusion: Vitamin D deficiency is common in critically ill cancer patients requiring ICU admission, but its impact on short-term mortality in this group is uncertain. The observed association of severe vitamin D deficiency with the post-ICU outcome warrants clinical consideration and further study.Cancer patients in ICU with low vitamin D were 3.4 X more likely to die within a year – Dec 2020
338 visitors, last modified 31 Dec, 2020,
- Breast Cancer and VDR